You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
|
|---|---|
| Published in |
Breast Cancer Research, November 2013
|
| DOI | 10.1186/bcr3577 |
| Pubmed ID | |
| Authors |
Clifford Hudis, Charles Swanton, Yelena Y Janjigian, Ray Lee, Stephanie Sutherland, Robert Lehman, Sarat Chandarlapaty, Nicola Hamilton, Devika Gajria, James Knowles, Jigna Shah, Keith Shannon, Ernestina Tetteh, Daniel M Sullivan, Carolina Moreno, Li Yan, Hyo Sook Han |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 29% |
| Germany | 1 | 14% |
| Unknown | 4 | 57% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 71% |
| Scientists | 2 | 29% |
Mendeley readers
The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 1% |
| Germany | 1 | 1% |
| Unknown | 98 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 20 | 20% |
| Researcher | 19 | 19% |
| Student > Master | 13 | 13% |
| Student > Bachelor | 8 | 8% |
| Other | 6 | 6% |
| Other | 13 | 13% |
| Unknown | 21 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 22 | 22% |
| Agricultural and Biological Sciences | 14 | 14% |
| Biochemistry, Genetics and Molecular Biology | 10 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 7% |
| Economics, Econometrics and Finance | 5 | 5% |
| Other | 15 | 15% |
| Unknown | 27 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2015.
All research outputs
#5,251,603
of 25,413,176 outputs
Outputs from Breast Cancer Research
#617
of 2,057 outputs
Outputs of similar age
#56,729
of 315,754 outputs
Outputs of similar age from Breast Cancer Research
#9
of 31 outputs
Altmetric has tracked 25,413,176 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,057 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 315,754 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.